Osimertinib in Stage III EGFR -Mutated NSCLC - Game, Set, Match.
Autor: | Leighl NB; From Princess Margaret Cancer Centre and the University of Toronto, Toronto. |
---|---|
Jazyk: | angličtina |
Zdroj: | The New England journal of medicine [N Engl J Med] 2024 Aug 15; Vol. 391 (7), pp. 652-654. |
DOI: | 10.1056/NEJMe2406495 |
Databáze: | MEDLINE |
Externí odkaz: |